Veritas, AZB act on Swedish firm Recipharm’s acquisition of Kemwell businesses

Recipharm AB, a Swedish a pharmaceutical contract development and manufacturing organisation (CDMO) is acquiring Kemwell’s CDMO businesses in India, US and Sweden in a strategic deal worth $ 205 million (1360 crore).